RXRX | Recursion Pharmaceuticals, Inc. |
Biological Products (no Diagnostic Substances) |
Book value per $ invested | $ 0.36 |
Leverage | 27.80% |
Market Cap | $ 1.5B |
PE | 0.00 |
Dividend Yield | 0.00% |
Profit | $ -374.7m |
Margin | -494.06% |
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that decodes biology by integrating technological innovations in biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company is headquartered in Salt Lake City, Utah.